Home › Therapeutic areas › Metabolic › Prader-Willi Syndrome

Prader-Willi Syndrome (4 companies)

Companies with an active program in Prader-Willi Syndrome.

Ticker Company Therapeutic areas Programs Lead stage Mkt cap Programs
AARD Aardvark Therapeutics DermatologyMetabolic+1 Rare 1 Phase 3 $25.2M 3
HRMY Harmony Biosciences MetabolicNeurology Rare 2 Approved $1.94B 17
RLMD Relmada Therapeutics MetabolicNeurology+1 Rare 1 Phase 2 $321M 4
RYTM Rhythm Pharmaceuticals Metabolic Rare 3 Approved $8.08B 14